IIS Aragon

20 March, 2025

The Aragon Health System Biobank launches its monthly newsletter

Published monthly, the newsletter will provide information of interest on the operation of the Biobank, the latest developments in the Biobank's work, and its collaboration with various IIS Aragón groups, among others.
20 March, 2025

Breastfeeding attenuates the genetic predisposition to obesity in adolescence

The 'Growth, exercise, nutrition and development (GENUD)' group (GIIS066) from the IIS Aragón and the University of Zaragoza has published a study in the journal Pediatric Obesity highlighting the protective role of breastfeeding against obesity, after analyzing data from 715 European adolescents.
19 March, 2025

Ignacio Ochoa Garrido: “Don't try to cure diseases on the first day; science is an endurance race.”

In this interview, IIS Aragón researcher talks about his work leading the Tissue Microenvironment Lab (TME Lab) (GIIS018) group and his lines of research.
14 March, 2025

Aragonese researchers discover a new marker for detecting cardiovascular risk in patients with sleep apnea.

The study is being promoted by the "Precision Medicine in Respiratory Diseases" (GIIS041) group at the IIS Aragón. The research focuses on how obstructive sleep apnea affects the heart and blood vessels.
12 March, 2025

The Diario de Teruel interviews Rebeca Sanz Pamplona, ​​a researcher at the IIS Aragón

The principal investigator of the 'Cancer Heterogeneity and Immunomics' (GIIS110) group has been included in the Pioneers 2025 calendar published by the Teruel Provincial Council.
11 March, 2025

Registrations are now open for the IV Aragonese Conference on Humanization in Breast Cancer

"Discovering experiences" will take place on April 10 at the Patio de la Infanta of the Ibercaja Foundation in Zaragoza at 17:00 p.m. The IIS Aragón is organizing this event with free admission upon prior registration.
10 March, 2025

Aspirin, a new ally against cancer: metastasis is stopped in a novel experiment with mice

This common drug can prevent T cells from being inhibited, improving their ability to destroy cancer cells. Ángel Lanas, scientific director of the IIS Aragón, explains this to Science Media Centre.